Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Recent studies have
identified the key role of crosstalk between dysregulated epithelial cells, mesenchymal …

The microbiota colonized in the human body has a symbiotic relationship with human body
and forms a different microecosystem, which affects human immunity, metabolism …

Rationale: Idiopathic pulmonary fibrosis (IPF) causes considerable global morbidity and
mortality, and its mechanisms of disease progression are poorly understood. Recent …

This document is an international evidence-based guideline on the diagnosis and
management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American …

The lymphatic vasculature has traditionally been thought to play a passive role in the
regulation of immune responses by transporting antigen presenting cells and soluble …

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable
morbidity and mortality. Cigarette smoking is one of the most recognized risk factors for …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unknown origin
characterized by progressive scarring of the lung leading to irreversible loss of function …

Development of persistent Th2 responses in asthma and chronic helminth infections are a
major health concern. IL-10 has been identified as a critical regulator of Th2 immunity, but …

Immune cells have been implicated in idiopathic pulmonary fibrosis (IPF), but the
phenotypes and effector mechanisms of these cells remain incompletely characterized. We …

Die idiopathische pulmonale Fibrose (IPF) ist eine schwerwiegende und in der Regel zum
Tod führende Erkrankung, die bisher nur unzureichend behandelt werden kann …